Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Use of Diagnostic AI for Lung Cancer in Practice

NCT03780582 is registered in ClinicalTrials.gov with Ensemble Group Holdings, LLC as lead sponsor.

NCT NCT03780582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03780582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Use of Diagnostic AI for Lung Cancer in Practice
Lead sponsor
Ensemble Group Holdings, LLC
Phase
Not applicable
Overall status
Unknown status
Start date
December 14, 2018
Completion date
December 15, 2019
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer